Quality Data Model December 2012

Similar documents
Quality Data Model (QDM) Style Guide. QDM (version MAT) for Meaningful Use Stage 2

emeasures: Everything You Want To Know

2) The percentage of discharges for which the patient received follow-up within 7 days after

Meaningful Use Stage 2 Clinical Quality Measures Are You Ready?

2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY

CMS QRDA Category I Implementation Guide Changes for CY 2018 for Hospital Quality Reporting

Pilot Results. Beth Israel Deaconess Medical Center (BIDMC) Massachusetts ehealth Collaborative (MAeHC)

Stage 2 Eligible Professional Meaningful Use Core Measures Measure 15 of 17 Last Updated: November 2013

Hospital Inpatient Quality Reporting (IQR) Program

Maria Durham OCSQ 3/15/2011

Electronic Clinical Quality Measures (ecqms) for Hospitals: What You Need to Know

Copyright All Rights Reserved.

Stage 2 Eligible Hospital and Critical Access Hospital Meaningful Use Core Measures Measure 12 of 16 Date issued: May 2013

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 537 of 593

Measure #137 (NQF 0650): Melanoma: Continuity of Care Recall System National Quality Strategy Domain: Communication and Care Coordination

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #137 (NQF 0650): Melanoma: Continuity of Care Recall System National Quality Strategy Domain: Communication and Care Coordination

Measure #137 (NQF 0650): Melanoma: Continuity of Care Recall System National Quality Strategy Domain: Communication and Care Coordination

Updated 2017 Medicaid EHR Incentive Program Requirements For Eligible Providers (EP)

MEANINGFUL USE STAGE 2

IT Enabled Quality Measurement IOM Dec 2012

Using Centricity Electronic Medical Record Meaningful Use Reports Version 9.5 January 2013

Note: Every encounter type must have at least one value designated under the MU Details frame.

Table of Contents 2017 MIPS GUIDE 12/29/2017

ecw and NextGen MEETING MU REQUIREMENTS

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Hospital IQR Program Hybrid Hospital-Wide 30-Day Readmission Measure Core Clinical Data Elements for Calendar Year 2018 Voluntary Data Submission

Eligible Professional Core Measure Frequently Asked Questions

Troubleshooting Audio

Troubleshooting Audio

Quality ID #288: Dementia: Caregiver Education and Support National Quality Strategy Domain: Communication and Care Coordination

Jason C. Goldwater, MA, MPA Senior Director

Preparing for the 2018 EHR Medicaid Incentive Payment Program

Quality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

COLORADO STATE INNOVATION MODEL Clinical Quality Measure Specifications Guidebook

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Achieving Meaningful Use with Centricity Electronic Medical Record

Measure #138: Melanoma: Coordination of Care National Quality Strategy Domain: Communication and Care Coordination

Hospital Inpatient Quality Reporting (IQR) Program

Troubleshooting Audio

Meaningful Use Stage 1 Guide for 2013

The Joint Commission's Performance Measurement Journey

HIT Standards Committee Clinical Quality Workgroup and Vocabulary Task Force

Meaningful Use and PCC EHR

Measures Reporting for Eligible Hospitals

Care360 EHR Frequently Asked Questions

Clinical Summary. Empowering Extraordinary Patient Care

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

EHR Incentives. Profit by using LOGO a certified EHR. EHR vs. EMR. PQRI Incentives. Incentives available

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

CHCANYS NYS HCCN ecw Webinar

Troubleshooting Audio

Merit-Based Incentive Payment System (MIPS) Advancing Care Information Performance Category Measure

PQRS and Other Incentive Programs

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

HIE Implications in Meaningful Use Stage 1 Requirements

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Measure #47 (NQF 0326): Care Plan National Quality Strategy Domain: Communication and Care Coordination

The Pain or the Gain?

Stage 1. Meaningful Use 2014 Edition User Manual

Merit-Based Incentive Payment System (MIPS) Advancing Care Information Performance Category Transition Measure 2018 Performance Period

Measure #356: Unplanned Hospital Readmission within 30 Days of Principal Procedure National Quality Strategy Domain: Effective Clinical Care

Quality Payment Program: The future of reimbursement

Meaningful Use Stages 1 & 2

Hidden ecqm Dangers and How to Avoid Them

Calendar Year 2014 Medicare Physician Fee Schedule Final Rule

INTERGY MEANINGFUL USE 2014 STAGE 1 USER GUIDE Spring 2014

Merit-Based Incentive Payment System (MIPS) Promoting Interoperability Performance Category Measure 2018 Performance Period

Falcon Quality Payment Program Checklist- 2017

Quality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Stage 2 Meaningful Use Final Rule CPeH Advocacy Opportunities

Version 11.5 Patient-Centered Medical Home (PCMH) 2014 Reference Guide for Sevocity Users

Detailed Analysis of the Final Rules on Stage 2 of Meaningful Use

Meaningful Use Modified Stage 2 Audit Document Eligible Hospitals

Medicaid Electronic Health Records Meaningful Use. Lisa Reuland, Program Manager October 15, 2015

Consolidated CDA Basics. Lisa R. Nelson, Lantana Consulting Group

Clinical Quality Measures Barbara Connors, DO, MPH Chief Medical Officer CMS Region III

Appendix 5. PCSP PCMH 2014 Crosswalk

9/28/2011. Learning Agenda. Meaningful Use and why it s here. Meaningful Use Rules of Participation. Categories, Objectives and Thresholds

Quality ID #424 (NQF 2681): Perioperative Temperature Management National Quality Strategy Domain: Patient Safety

Troubleshooting Audio

Tips for PCMH Application Submission

Merit-Based Incentive Payment System (MIPS) Promoting Interoperability Performance Category Measure 2018 Performance Period

CMS Meaningful Use Incentives NPRM

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.

Terminology in Healthcare and

Meaningful Use for Eligible Providers. Session Four: ARRA Meaningful Use Reporting, Registration, and Attestation

PCSP 2016 PCMH 2014 Crosswalk

Meaningful use glossary and requirements table

Russell B Leftwich, MD

Outpatient Quality Reporting Program

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

Roll Out of the HIT Meaningful Use Standards and Certification Criteria

2015 Meaningful Use and emipp Updates (for Eligible Professionals)

Transcription:

Quality Data Model December 2012 Chris Millet, MS Senior Project Manager, Health IT Juliet Rubini, RN-BC, MSN, MSIS Senior Project Manager, Health IT

Agenda 12:00 pm Welcome and Introductions 12:05 pm The Quality Data Model (QDM): A Brief Introduction and Role in Quality Measurement 12:15 pm What s New with the QDM 12:30 pm Potential Future Enhancements 12:50 pm QDM and the Measure Authoring Tool 1:00 pm QDM Utility Both Within and Outside of Quality Measurement 1:15 pm Questions and Discussion 2

QDM: A Brief Introduction and Role in Quality Measurement 3

The Performance Measurement Enterprise QDM, MAT, emeasure Feasibility, Critical Paths, emeasure Collaborative 4

Quality Data Model (QDM): Overview QDM: What is It? A structure to represent quality measures precisely and accurately in a standardized format that can be used across electronic patient care systems Role in Quality Measurement Provides a standard way to describe concepts clearly and consistently for use across all quality measures Creates a common language across all healthcare stakeholders so quality measurement data can be consistently represented, captured, and shared across EHRs and other electronic patient care systems Backbone for the Measure Authoring Tool

QDM: Basic Structure 6

Example 7

emeasure Lifecycle Quality Measure Quality Data Model Measure Authoring Tool emeasure EHR Inform all Stakeholders Real-Time Information to Clinician Electronic Reporting and Sharing Develop Performance Measures Capture Data Provide Care 8

Sample Measure Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed a lipid-lowering therapy* Initial Patient Population Patients aged 18 years and older before the start of the measurement period. Patients that have a documented diagnosis of coronary artery disease before or simultaneously to encounter date Patients who have at least 2 outpatient or nurse facility encounters during the measurement period Denominator Numerator Exclusions Patients aged 18 years and older with a diagnosis of coronary artery disease Patients who were prescribed lipid-lowering therapy Patients who have documentation of a medical, system or patient reason for not prescribed lipid lowering therapy *Note: this emeasure is not real; it is intended for the sole purpose of showing an example of an emeasure

What data elements do we need? Patients who What kind of data are we dealing with? What about the data? How do we define this data? Are diagnosed with Coronary Artery Disease Were prescribed Lipid-lowering Therapy Have had at least two encounters during the measurement period Diagnosis Active ICD-9, ICD-10, SNOMED-CT Medication Encounters Administered Order Dispensed Active RxNorm CPT Are at least 18 years old or older Patient Characteristic LOINC Quality Data Model 10

Human Readable - Header

Initial Patient Population = AND: "Patient Characteristic: birth date" >= 18 year(s) starts before start of "Measurement Period" AND: Count >= 2 of: OR: "Encounter: Nursing Facility Encounter" OR: "Encounter: Outpatient Encounter" AND: OR: "Procedure, Performed: Cardiac Surgery" starts before or during OR: "Encounter: Nursing Facility Encounter" OR: "Encounter: Outpatient Encounter" OR: "Diagnosis, Active: CAD includes MI" Denominator = AND: "Initial Patient Population" Denominator Exclusions = None Numerator = AND: OR: "Medication, Active: Lipid Lowering Therapy" OR: "Medication, Order: Lipid Lowering Therapy" during "Measurement Period" Denominator Exceptions = AND: OR: "Medication, Order not done: Medical Reason HL7" for "Lipid Lowering Therapy RxNorm Value Set" OR: "Medication, Order not done: System Reason HL7" for "Lipid Lowering Therapy RxNorm Value Set" Data criteria (QDM Data Elements) "Diagnosis, Active: CAD includes MI" using "CAD includes MI Grouping Value Set (2.16.840.1.113883.3.560.4.13.25)" "Encounter: Nursing Facility Encounter" using "Nursing Facility Encounter CPT Value Set (2.16.840.1.113883.3.560.4.13.26)" "Encounter: Outpatient Encounter" using "Outpatient Encounter CPT Value Set (2.16.840.1.113883.3.560.4.13.27)" "Medication, Active: Lipid Lowering Therapy" using "Lipid Lowering Therapy RxNorm Value Set (2.16.840.1.113883.3.560.4.13.29)" "Medication, Order: Lipid Lowering Therapy" using "Lipid Lowering Therapy RxNorm Value Set (2.16.840.1.113883.3.560.4.13.29)" "Medication, Order not done: Medical Reason HL7" using "Medical Reason HL7 HL7 Value Set (2.16.840.1.113883.3.560.4.13.30)" "Medication, Order not done: System Reason HL7" using "System Reason HL7 HL7 Value Set (2.16.840.1.113883.3.560.4.13.46)" "Patient Characteristic: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)" "Procedure, Performed: Cardiac Surgery" using "Cardiac Surgery SNOMED-CT Value Set (2.16.840.1.113883.3.560.4.13.31)" Supplemental Data Elements None

What s New with the QDM?

QDM 2012 Accomplishments QDM Development QDM June 2012 Update published for public comment Formation of QDM User Group with developers and contractors from the 2014 CQM development cycle QDM December 2012 version Supporting QDM Use Measure developer and contractor support for QDM usage in developing the 2014 clinical quality measures (CQMs) for Meaningful Use Stage 2 QDM Webinars (May and December) 14

What s New with the QDM: December 2012 Lessons Learned from 2014 Clinical Quality Measure Development 2014 CQM s (for Meaningful Use Stage 2) were the first quality measures to be developed exclusively using the QDM (via the Measure Authoring Tool (MAT)) 29 Eligible Hospital measures 64 Eligible Provider measures Identified opportunities for improvement in the QDM 15

What s New with the QDM Aligned the structure of the QDM with the version in the MAT: QDM June 2012 Update had introduced the concept of category and state pairs to replace the datatype structure QDM December 2012 version maintains the datatype structure This change is strategic to allow a common starting point for future QDM development 16

Potential Future Enhancements 17

Examples of Potential Future Enhancements Diagnosis datatypes Medication, discharge attribute additions Formalized order for operator calculation Definitions for timing elements 18

Diagnosis Datatypes Full expression of content within the Eligible Hospital Measures requires support for expression of discharge diagnosis and principal diagnosis Work continues on operational definitions of these terms as well as recommendations on how these concepts should be added to the QDM to ensure that HQMF and QRDA* representation of the concepts will be appropriate. *HQMF (health quality measures format) and QRDA (quality reporting document architecture) are HL7 standards that define the structure of emeasures and the reports generated from the measures by hospitals and providers 19

Medication, discharge attributes QDM enhancement required to support expression of discharge medications within the Eligible Hospital measures had difficulty expressing the concept of discharge medications A new datatype of the Medication category was added: Medication, discharge. The attributes for the Medication, active datatype were added to this datatype. Attributes like indication and instructions to patient have been identified as potential additions to this datatype 20

Formalized order for operation calculation The QDM needs a set way of "processing" the logical operators Similar to the way we use PEMDAS* for mathematical operators, the QDM needs a similar criteria for processing operators like 'FIRST' or 'AVERAGE HL7 standards will be consulted as a recommendation is developed *PEMDAS = Parenthesis, Exponents, Multiply, Divide, Add, Subtract 21

Definitions for timing elements The definition of certain timing elements within measures and the QDM (ex. days, months and calculations of the terms) was not interpreted in a standard way A proposal to use ISO definitions has been brought forth in other forums and is currently under consideration as a recommendation 22

QDM User Group 23

QDM User Group Group formed during the 2014 CQM development and QA Consists of stakeholders from: Measure development (and contractors) EHR vendors Measure implementers Mission is simple: Use the experience of those involved in the development and implementation of 2014 CQM s to help develop the QDM further 24

QDM User Group User group working methods: Smaller groups research a particular area for improvement in depth Then make recommendations to the larger group Interested in getting involved? Contact qdm@qualityforum.org 25

QDM and the Measure Authoring Tool 26

QDM and the Measure Authoring Tool QDM 2.1.1.1 (October2012) version currently implemented in MAT NQF will work with CMS as the MAT transitions to them in January 2013 NQF and CMS will keep all stakeholders updated on future QDM enhancements 27

Meaningful Use Stage 3: Potential Measurement Areas Data Concepts Care Team / Team Member Roles / Responsibilities Key owner for the care plan Primary contact / Additional contacts Practice identifier Precautions Shared agreement Watchful waiting Advanced directives Decision Modifiers Patient Instructions Patient Reported Outcomes Potential MU3 emeasures Measure assessing the use of shared decision making materials for patients with specific conditions Measure assess provider decision quality Measure assessing the presence of a completed comprehensive care plan Composite measure assessing closing the referral loop Measure of patient and family experience across a care transition 28

QDM Utility Both Within and Outside of Quality Measurement 29

Enabling QDM Use in Other Systems Problem: Other systems each need to program the QDM and HQMF templates QDM Web Service Diagnosis, Active definition xml Applications that may use the QDM Measure Authoring Tool Clinical Decision Support engines Web service can provide QDM info to multiple applications, ensuring consistent implementation and reduce duplicative work Other systems 30

Enabling QDM Use in Other Systems Problem: Other systems each need to program the QDM and HQMF templates Applications that may use the QDM Allows for Future Diagnosis, Innovation Active to Develop QDM Web Measure Service definition Authoring Tool Better Methods for emeasurement xml Clinical Decision Support engine Web service can provide QDM info to multiple applications, ensuring consistent implementation and reduce duplicative work Other systems 31

QDM: Looking Forward to 2013 QDM front end browser development Enhance the QDM to support emerging areas related to emeasures and Meaningful Use Continue to validate enhancements with QDM Users and Stakeholders Collaborate with CMS to update the version of the QDM in the MAT 32

Thank you! Questions? Chris: Cmillet@qualityforum.org Juliet: Jrubini@qualityforum.org